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Lesions of anogenital mammary-like glands are rare, and only 44 female cases have been reported. Herein, we
describe a particularly rare case of phyllodes tumor of anogenital mammary-like glands in a 41-year-old male
presenting anal bleeding. Papillectomy was performed. The excised tumor was circumscribed in shape, and after it
was sliced into sections, it was noted that there were leaf-like slits on the surface of cut side. Under the microscope,
the tumor was found to be biphasic, with a bland glandular epithelium and low-to-intermediate cellular stroma,
which together created the leaf-like slits. Gynecomastoid hyperplasia was evident at the periphery. The epithelium
showed immuno-activity for ER, PR(focal), AR, and GCDFP-15. The stromal cells showed positive staining for CD34
and vimentin. The morphology and immunophenotype were similar to benign phyllodes tumors of breast. To the
best of our knowledge, this case report represents the first case of phyllodes tumor of anogenital mammary-like
glands with gynecomastoid hyperplasia at the periphery in a male patient. To make a diagnosis, we had to
differentiate this lesion from hidradenoma papilliferum of skin appendage, phyllodes tumor of ectopic prostatic
tissue, and other tumors of anogenital mammary-like glands analogous to the breast tumor (e.g., fibroadenoma
phyllodes, periductal stromal sarcoma, and spindle cell carcinoma). While gynecomastia of male breast is usually a
result of hormone imbalance, our patient’s tumor did not seem to be related to peripheral hormone status in the
anogenital mammary-like glands. Nevertheless, because hormone imbalance has been strongly related to male
breast cancer, hormone levels may need to be followed in male patients who have this rare malady.
Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/1509145815899177
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GynecomastiaBackground
Ectopic breast tissue in the vulva was first identified
by Hartung in 1872, and it has long been considered
caudal remnants of the milk ridges, though mam-
mary type tissue has been reported to be a normal
constituent of the anogenital area (1991) [1]. Today
such tissues in the anal area are called anogenital
mammary-like glands (AGMLG). There have been re-
ports of lesions arising in AGMLG that resemble
breast neoplasms, including benign or malignant, epi-
thelial and/or stromal neoplasms. Phyllodes tumor or
other fibroepithelial tumors of AGMLG is extremely* Correspondence: ssssnowkimo@gmail.com
1Department of Pathology and Laboratory Medicine, Kaohsiung Veterans
General Hospital, Kaohsiung, Taiwan
Full list of author information is available at the end of the article
© 2013 Ho et al.; licensee BioMed Central Ltd.
Commons Attribution License (http://creativec
reproduction in any medium, provided the orrare and has previously been found in females exclu-
sively [2-4]. Herein, we present the first case of a male
patient found to have low-grade phyllodes tumor of
AGMLG. Gynecomastoid hyperplasia of AGMLG was
also identified at periphery of tumor. Because all fibro-
adenomas of the male breast have been found with con-
current gynecomastia and patients with these lesions
have clear hormone imbalances [5], we assumed that
the phyllodes tumor or other fibroepithelial neoplasms
of AGMLG with gynecomastoid hyperplasia at the
periphery might also suggest possible hormone im-
balance. However, peripheral estrogen/androgen ratio
was found to be unchanged.This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 2 Gross features. The tumor appeared circumscribed. The
cut sections showed leaf-like slits.
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Case report
A 41-year-old Taiwanese male with a previous history of
hypertension and major depressive disorder under con-
trol with medication came to the outpatient clinic of the
Division of Gastroenterology complaining of recent anal
bleeding. Physical examination and colon fiberoscopy
revealed a subepithelial tumor at anal verge (Figure 1),
for which he received a papillectomy.
Materials and methods
For pathology analysis, representative specimens were
fixed in 4% buffered formalin and embedded in par-
affin. They were sliced into serial sections (4um) and
stained with hematoxylin-eosin. Immunohistochemistry
stains were performed using Leica BOND-MAX. We
performed immunostaining for: estrogen receptor (Clone
6F11); progesterone (Clone 16); androgen receptor
(Clone AR27); gross cystic disease fluid protein 15
(Clone 23A3); vimentin (Clone SRL33); CD34 (Clone
QBEnd/10); actin (Clone HHF35); smooth muscle
actin(SMA) (Clone alpha sm-1); Ki-67(MIB-1) (Clone
GM010); Cytokeratin 7(CK7) (CloneOV-TL 12/30); Pros-
tatic Acid Phosphatase (PSAP) (Clone PASE/4LJ); prostate-
specific antigen (PSA) (Clone 35H9); Pan-cytokeratin
(Clone AE1/AE3).
Results
Grossly, the subepithelial tumor measured 2.4 cm at the
greatest circumference. It was grey-white, mildly firm,
well-circumscribed with a cleft-like appearance (Figure 2).
The skin overlying the anal tumor had no remarkable
findings.
Microscopically, the circumscribed tumor was com-
posed of the biphasic components of glandular epitheliumFigure 1 Colofibroscopic finding. The endoscopic findings
revealed a subepithelial tumor at anal verge.and stromal component, together forming leaf-like slits
(Figure 3a). The glandular epithelium consisted of a lu-
minal ductal epithelium layer and a basal myoepithelial
layer. Stroma showed low-to-intermediate cellularity
(Figure 3d-e). An increase in Ki-67 proliferative index was
found in stromal cells. (Figure 4f). The morphology of the
tumor was similar to that of the mammary glands under
phyllodes change. At the peripheral of tumor, both ductal
epithelium and periductal stroma proliferated without
lobular pattern (Figure 3f). The stroma were myxoid or
edematous in appearance. These characteristics were simi-
lar to those of gynecomastia on the male breast [5].
In the immunohistochemical study, the luminal ductal
epithelium showed positive for ER and PR and focal
positive for AR and GCDFP-15 (Figure 4a-d). The
basal myoepithelial cells showed positive for CK5/6,
actin, and SMA. The stromal cells showed positive
for CD34 (Figure 4e) and vimentin and negative for
actin and SMA.
The patient remained in the hospital for three days
and recovery was unremarkable. He was discharged on
day 4. As of 20 months post-surgery, there was no
local recurrence.
Discussion
Lesions of AGMLG present as a spectra of morpho-
logic changes synonymous with those in the breast,
including lactating adenoma, hidradenoma papil-
liferum, syringoadenoma papilliferum, fibroadenoma,
phyllodes tumor, pseudoangiomatous stromal hyperpla-
sia, extramammary Paget’s disease and other malignan-
cies arising from AGMLG [6]. Benign changes, such as
apocrine, oxyphilic or squamous metaplasia, myo-
epithelial hyperplasia or clear cell metaplasia, lactation-
like change and florid epithelial hyperplasia, have
also occasionally been identified [6]. To date, fibro-
epithelial lesions of AGMLG have only been reported
in 44 female cases. As far as we know, there has been
Figure 3 Microscopic findings. a) At the low power field, the tumor was found to be well-circumscribed. Leaf-like growth pattern was clearly
depicted. b) The overlying skin and skin appendage of this tumor showed no remarkable change. c) The epithelium was composed of double
layers. The stroma showed low cellularity. d) However, there is other area of tumor which shows increased stromal cellularity in low-to
-intermediate degree. e) At high power field, stormal hypercellularity and cell atypism were identified. f) At peripheral, gynecomastoid hyperplasia
featuring proliferation of both ductal and stromal cells was found.
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male patient.
We performed differential diagnoses to exclude pos-
sible hidradenoma papilliferum of skin appendage, phyl-
lodes tumor of ectopic prostatic tissue, and tumors of
AGMLG which are analogous with the breast neoplasm.
Hidradenoma papilliferum can also be found in the anal
region [7-9]. However, hidradenoma papilliferum has a
more complex papillary structure than the leaf-like pat-
tern of benign phyllodes tumors [10]. In hidradenoma
papilliferum, glandular secretion is incapacitated. Be-
cause lesions of mammary glands and sweat glands stain
for ER and GCDFP-15, immunohistochemistry may not
be used to distinguish hidradenoma papilliferum from
mammary lesions [8]. Phyllodes tumor has been foundin ectopic prostate tissue, mostly in female patients, the
most common locations being the vulva, vagina, cervix,
urinary bladder and anal canal [11-13]. Gynecomastoid
hyperplasia around the main lesion may cause a patholo-
gist to suspect residual normal prostate glands. Mammary
glands may show weakly positive for PSA. However, a posi-
tive finding of CK7 and negative finding for PSAP may help
exclude the possibility of a prostatic origin (Figure 4g-h)
[11]. There are other tumors homologous to the breast
tumor. One, periductal stromal sarcoma, also has a biphasic
growth pattern. However, it does not have the leaf-like
appearance of intracanicular growth pattern but rather a
solid growth appearance of a pericanalicular pattern [14].
Another such tumor is spindle cell carcinoma. The epitheli-
oid nests of this tumor may merge with spindle stromal
Figure 4 Immunohistochemistry. a) ER. b) PR. c) AR. d) GCDFP-15. e) CD34. f) Ki-67. g) CK7. h) PSAP. i) AE1/AE3.
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cells clearly (Figure 4i) [14]. Still another such tumor is
fibroadenoma phyllodes, which is a histological feature
similar to that of low-grade phyllodes tumor [15]. It can be
difficult to distinguish the two because there is a continuum
of morphologic findings. However, if the lesion has well-
formed leaf-like slits and the hypocellular stroma appears
to the degree that is found in fibroadenoma, it is called
fibroadenoma phyllodes [15]. In our case, there was in-
creased stromal cellularity and cell atypia. The proliferative
index of stromal cells was found to be increased when
viewing the Ki-67 Immunostain (Figure 4f). Together, these
characteristics help distinguish phyllodes tumor from fibro-
adenoma phyllodes. Regardless, in the mammary gland,
both fibroadenoma and phyllodes tumor carry risk of local
recurrence.
Benign lesions in AGMLG outnumber malignant ones
more than they do in the breast, possibly because the
anus has more superficial locations [6]. In all patients
reported previously, there was no recurrence of the
tumor after excision [6]. As of twenty months follow-up,no local recurrence was found in our case. It is unclear
whether phyllodes tumor of AGMLG has a better prog-
nosis than phyllodes tumor of the mammary gland. Be-
cause it is difficult to predict behavior of this tumor in
mammary glands, the possibility of recurrence locally
cannot be totally excluded. Likewise, it would be prudent
to closely follow-up phyllodes tumor of AGMLG post-
surgery.
According to Sandra J. , there is always concurrent
gynecomastia in fibroadenoma of breast in men [5].
Both gynecomastia and male breast cancer share hormo-
nal imbalance as a same factor. Exogenous estrogen use
in the male patient is evident [5]. Because our case had
gynecomastoid hyperplasia and tumor on his AGMLG,
we were concerned that he may also have a hormone
imbalance as well as gynecomastia or tumor on the
breast. However, his hormone levels (prolactin, beta-
hCG, testosterone, E2, LH, FSH, T3, T4) were within
normal range, and no gynecomastia or tumor was found
in breast. These negative findings could be interpreted
to suggest that our patient’s phyllodes tumor and
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localized hormone change. Although we found no per-
ipheral hormone change, it might be still wise to moni-
tor hormone levels in other such patients because of the
known strong association between hormone level and
gynecomastia as well as male breast cancer.
The alterations in ratio of androgen to estrogen may be
influenced by many factors [16]. In middle-aged men,
changes in this ratio can be caused by testicular or
adrenal tumors, hormone-secreting tumors, hormone de-
ficiency, prostate cancer, obesity, liver or renal disease,
medical history of disease or drug abuse. Our male
patient had normal hormone status (prolactin, beta-hCG,
testosterone, E2, LH, FSH, T3, T4), and denied taking
any drugs except for those he was taking for hyperten-
sion and depression. However, in such patients, it is
necessary to take a careful medical and drug-use history as
well as perform comprehensive evaluations, including
physical examination, imaging, and laboratory evaluations.
Conclusions
In summary, herein we have introduced the first case of
a male patient with a phyllodes tumor in anogenital
mammary-like glands. Gynecomastoid hyperplasia of
AGMLG was also identified, though no hormone imbal-
ance or breast manifestations were found. We are
unsure whether the phyllodes tumor of AGMLG lesion
in our male patient was indeed a localized lesion or
whether he would develop breast cancer in the future.
Further study is needed to establish the clinical signifi-
cance of this manifestation.
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